JP5670181B2 - Methods for preparing active ingredients in hot spring water and compositions containing them - Google Patents
Methods for preparing active ingredients in hot spring water and compositions containing them Download PDFInfo
- Publication number
- JP5670181B2 JP5670181B2 JP2010506932A JP2010506932A JP5670181B2 JP 5670181 B2 JP5670181 B2 JP 5670181B2 JP 2010506932 A JP2010506932 A JP 2010506932A JP 2010506932 A JP2010506932 A JP 2010506932A JP 5670181 B2 JP5670181 B2 JP 5670181B2
- Authority
- JP
- Japan
- Prior art keywords
- water
- hot spring
- spring water
- mineral
- bacteria
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims description 190
- 239000000203 mixture Substances 0.000 title claims description 74
- 238000000034 method Methods 0.000 title claims description 39
- 239000004480 active ingredient Substances 0.000 title claims description 11
- 241000894006 Bacteria Species 0.000 claims description 39
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 37
- 239000011707 mineral Substances 0.000 claims description 36
- 239000002609 medium Substances 0.000 claims description 27
- 239000000284 extract Substances 0.000 claims description 23
- 239000002537 cosmetic Substances 0.000 claims description 20
- 238000012258 culturing Methods 0.000 claims description 17
- 239000001963 growth medium Substances 0.000 claims description 16
- 230000003204 osmotic effect Effects 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 10
- 241000233866 Fungi Species 0.000 claims description 8
- 239000012153 distilled water Substances 0.000 claims description 8
- 230000001580 bacterial effect Effects 0.000 claims description 7
- 230000000694 effects Effects 0.000 claims description 6
- 230000000243 photosynthetic effect Effects 0.000 claims description 6
- 238000000855 fermentation Methods 0.000 claims description 5
- 230000004151 fermentation Effects 0.000 claims description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 150000002772 monosaccharides Chemical class 0.000 claims description 3
- 230000006641 stabilisation Effects 0.000 claims description 2
- 238000011105 stabilization Methods 0.000 claims description 2
- 235000010755 mineral Nutrition 0.000 description 33
- 239000002028 Biomass Substances 0.000 description 25
- 210000003491 skin Anatomy 0.000 description 14
- 239000003921 oil Substances 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000000499 gel Substances 0.000 description 10
- 239000006210 lotion Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- 239000006071 cream Substances 0.000 description 9
- 239000000839 emulsion Substances 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 210000004209 hair Anatomy 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 239000011573 trace mineral Substances 0.000 description 7
- 235000013619 trace mineral Nutrition 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 6
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 5
- 239000002671 adjuvant Substances 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- -1 for example Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000003643 water by type Substances 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 210000002510 keratinocyte Anatomy 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000000699 topical effect Effects 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 239000003349 gelling agent Substances 0.000 description 3
- 229960001031 glucose Drugs 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 239000002453 shampoo Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000012134 supernatant fraction Substances 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 2
- 239000011475 Accrington brick Substances 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 101100181431 Homo sapiens LCE3D gene Proteins 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- 102100024572 Late cornified envelope protein 3D Human genes 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 108090000526 Papain Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 241000206608 Pyropia tenera Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000007957 coemulsifier Substances 0.000 description 2
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 235000004626 essential fatty acids Nutrition 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000006260 foam Substances 0.000 description 2
- 230000037406 food intake Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 208000024963 hair loss Diseases 0.000 description 2
- 230000003676 hair loss Effects 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000004973 liquid crystal related substance Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229940055729 papain Drugs 0.000 description 2
- 235000019834 papain Nutrition 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229910052814 silicon oxide Inorganic materials 0.000 description 2
- 239000010802 sludge Substances 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- CRDAMVZIKSXKFV-FBXUGWQNSA-N (2-cis,6-cis)-farnesol Chemical compound CC(C)=CCC\C(C)=C/CC\C(C)=C/CO CRDAMVZIKSXKFV-FBXUGWQNSA-N 0.000 description 1
- 239000000260 (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol Substances 0.000 description 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- IXIGWKNBFPKCCD-UHFFFAOYSA-N 2-hydroxy-5-octanoylbenzoic acid Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(O)=O)=C1 IXIGWKNBFPKCCD-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- ZGIGZINMAOQWLX-NCZFFCEISA-N 3,7,11-Trimethyl-2,6,10-dodecatrienyl acetate Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\COC(C)=O ZGIGZINMAOQWLX-NCZFFCEISA-N 0.000 description 1
- 235000007173 Abies balsamea Nutrition 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- 241000190909 Beggiatoa Species 0.000 description 1
- 241000190907 Beggiatoa alba Species 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- 244000146462 Centella asiatica Species 0.000 description 1
- 235000004032 Centella asiatica Nutrition 0.000 description 1
- 235000002414 D-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000011740 D-alpha-tocopherylacetate Substances 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004258 Ethoxyquin Substances 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- ZGIGZINMAOQWLX-UHFFFAOYSA-N Farnesyl acetate Natural products CC(C)=CCCC(C)=CCCC(C)=CCOC(C)=O ZGIGZINMAOQWLX-UHFFFAOYSA-N 0.000 description 1
- 241001210405 Flexithrix Species 0.000 description 1
- 241001210403 Flexithrix dorotheae Species 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 244000018716 Impatiens biflora Species 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- 241000190573 Leucothrix Species 0.000 description 1
- 241000190572 Leucothrix mucor Species 0.000 description 1
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- SXZWBNWTCVLZJN-NMIJJABPSA-N N-tricosanoylsphing-4-enine-1-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)[C@H](O)\C=C\CCCCCCCCCCCCC SXZWBNWTCVLZJN-NMIJJABPSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241001303601 Rosacea Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241001478896 Sphaerotilus natans Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 241000947895 Thiotrichaceae Species 0.000 description 1
- 241001248478 Thiotrichales Species 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241000863000 Vitreoscilla Species 0.000 description 1
- 241000863027 Vitreoscilla beggiatoides Species 0.000 description 1
- 241000863026 Vitreoscilla filiformis Species 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 229920000800 acrylic rubber Polymers 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002141 anti-parasite Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003096 antiparasitic agent Substances 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 description 1
- 229940011658 asiatic acid Drugs 0.000 description 1
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 description 1
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 1
- 229940022757 asiaticoside Drugs 0.000 description 1
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 1
- 230000001651 autotrophic effect Effects 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229940094199 black currant oil Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000013270 controlled release Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 229940039770 d-alpha-tocopheryl acetate Drugs 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000009274 differential gene expression Effects 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 229940117373 dl-alpha tocopheryl acetate Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 description 1
- DECIPOUIJURFOJ-UHFFFAOYSA-N ethoxyquin Chemical compound N1C(C)(C)C=C(C)C2=CC(OCC)=CC=C21 DECIPOUIJURFOJ-UHFFFAOYSA-N 0.000 description 1
- 235000019285 ethoxyquin Nutrition 0.000 description 1
- 229940093500 ethoxyquin Drugs 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229940043259 farnesol Drugs 0.000 description 1
- 229930002886 farnesol Natural products 0.000 description 1
- 229940007703 farnesyl acetate Drugs 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000000054 fungal extract Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 229940100242 glycol stearate Drugs 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000000118 hair dye Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 238000001155 isoelectric focusing Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 229920006008 lipopolysaccharide Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- CBKLICUQYUTWQL-XWGBWKJCSA-N methyl (3s,4r)-3-methyl-1-(2-phenylethyl)-4-(n-propanoylanilino)piperidine-4-carboxylate;oxalic acid Chemical compound OC(=O)C(O)=O.CCC(=O)N([C@]1([C@H](CN(CCC=2C=CC=CC=2)CC1)C)C(=O)OC)C1=CC=CC=C1 CBKLICUQYUTWQL-XWGBWKJCSA-N 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000000282 nail Anatomy 0.000 description 1
- 239000007908 nanoemulsion Substances 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229940038384 octadecane Drugs 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-UHFFFAOYSA-N octinoxate Chemical compound CCCCC(CC)COC(=O)C=CC1=CC=C(OC)C=C1 YBGZDTIWKVFICR-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- 230000002018 overexpression Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000011837 pasties Nutrition 0.000 description 1
- 229940119519 peg-32 stearate Drugs 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- 239000010702 perfluoropolyether Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- CGIHFIDULQUVJG-UHFFFAOYSA-N phytantriol Chemical compound CC(C)CCCC(C)CCCC(C)CCCC(C)(O)C(O)CO CGIHFIDULQUVJG-UHFFFAOYSA-N 0.000 description 1
- CGIHFIDULQUVJG-VNTMZGSJSA-N phytantriol Natural products CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(O)[C@H](O)CO CGIHFIDULQUVJG-VNTMZGSJSA-N 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000059 polyethylene glycol stearate Polymers 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 238000004094 preconcentration Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000003762 quantitative reverse transcription PCR Methods 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- WWDMJSSVVPXVSV-YCNIQYBTSA-N retinyl ester Chemical compound CC1CCCC(C)(C)C1\C=C\C(\C)=C\C=C\C(\C)=C\C(O)=O WWDMJSSVVPXVSV-YCNIQYBTSA-N 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 201000004700 rosacea Diseases 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000004174 sulfur cycle Methods 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 239000000606 toothpaste Substances 0.000 description 1
- 229940034610 toothpaste Drugs 0.000 description 1
- CRDAMVZIKSXKFV-UHFFFAOYSA-N trans-Farnesol Natural products CC(C)=CCCC(C)=CCCC(C)=CCO CRDAMVZIKSXKFV-UHFFFAOYSA-N 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 238000000539 two dimensional gel electrophoresis Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/08—Mineral waters; Sea water
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/02—Monosaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
本発明は、特に化粧品または医薬分野で使用する改善された特性を微生物に付与する、微生物の新規な培養方法に関する。本発明はまた、これらの方法によって得られる細菌またはその抽出物の、特に化粧品または皮膚使用を有する組成物の調製における使用にも関する。 The present invention relates to a novel method for culturing microorganisms that imparts improved properties to microorganisms, particularly for use in the cosmetic or pharmaceutical field. The invention also relates to the use of the bacteria obtained by these methods or extracts thereof, in particular in the preparation of compositions having cosmetic or skin use.
本発明は、Bergey's Manual of Systematic Bacteriology (vol. 3、sections 22 and 23、9th edition、1989)の分類にしたがって定義される非光合成性かつ非子実形成性の糸状菌(中でも、ベギアトア目(Beggiatoales)の系列に属する細菌、さらにとりわけベギアトア(Beggiatoa)属、ビトレオスチラ(Vitreoscilla)属、フレキシトリックス(Flexithrix)属またはロイコトリックス(Leucothrix)属に属する細菌が挙げられ得る)の培養に特に関する。 The present invention relates to non-photosynthetic and non-growth filamentous fungi (especially Beggiatoales) defined according to the classification of Bergey's Manual of Systematic Bacteriology (vol. 3, sections 22 and 23, 9th edition, 1989). ), And in particular culture of bacteria belonging to the genera Beggiatoa, Vitreoscilla, Flexithrix or Leucothrix).
そのようなベギアトア科(Beggiatoaceae)の細菌の培養について、穏やかに撹拌された培地中の発酵槽での増殖による培養が出願FR2283223に記載されている。 For the culture of such Beggiatoaceae bacteria, the culture by growth in a fermentor in a gently agitated medium is described in application FR2283223.
出願WO94/02158には、ベギアトアまたはビトレオスチラ属の細菌のエンベロープからの免疫調節組成物の調製が教示されている。これらの細菌は、蒸留水および炭素源としての単糖類、特にグルコースを用いて調製された培地において培養される。 Application WO94 / 02158 teaches the preparation of immunomodulatory compositions from the envelopes of bacteria of the genus Vegia toa or Vitreostilla. These bacteria are cultivated in a medium prepared with distilled water and monosaccharides, in particular glucose, as a carbon source.
さらに、こうして得られた糸状菌、または画分は、例えば、EP681831における老化の兆候に対抗すること、またはEP761204における敏感肌を治療することについて記載された有利な特性を示す。 Furthermore, the filamentous fungi, or fractions thus obtained show the advantageous properties described, for example, against the signs of aging in EP681831 or to treat sensitive skin in EP761204.
そのような微生物を生成する改善された方法を見出す必要性が依然として存在する。 There remains a need to find improved methods of producing such microorganisms.
本発明に関連して、鉱泉水によって糸状菌を培養するための培地に従来的に存在する蒸留水の全部または一部を置換することにより、改善された特性を示す細菌塊を得ることを可能にすることが見出された。 In connection with the present invention, it is possible to obtain a bacterial mass exhibiting improved properties by replacing all or part of the distilled water conventionally present in the medium for culturing filamentous fungi with mineral water Was found to be.
そのため、本発明の主題は、化粧品または皮膚用有効成分の調製方法であって、少なくとも1種の非光合成性かつ非子実形成性の糸状菌を、好ましくは硫黄不含である少なくとも1種の鉱泉水および/または温泉水を含む培地において培養するステップを含む方法である。 The subject of the present invention is therefore a method for the preparation of an active ingredient for cosmetics or skin, comprising at least one non-photosynthetic and non-growth filamentous fungus, preferably at least one sulfur-free A method comprising culturing in a medium containing mineral spring water and / or hot spring water.
亜硫酸水は、硫黄循環の役割を果たす独立栄養代謝を有する細菌を一般的に含む。本発明による硫黄不含水は、そのような亜硫酸還元細菌を実質的に含まない。 Sulfite water generally contains bacteria with autotrophic metabolism that play a role in the sulfur cycle. The sulfur-free water according to the present invention is substantially free of such sulfite reducing bacteria.
上記のように、非光合成性の糸状菌は、特にベギアトア目の系列に属する細菌、より詳細にはベギアトア属、ビトレオスチラ属、フレキシトリックス属またはロイコトリックス属に属する細菌を含む。 As mentioned above, non-photosynthetic filamentous fungi include, in particular, bacteria belonging to the order of Vegiatoa, more particularly bacteria belonging to the genus Begiatoa, Vitreostilla, Flexix or Leukotrix.
本発明による方法は、ビトレオスチラ属に属する細菌、より詳細にはビトレオスチラ・フィリフォルミス(Vitreoscilla filiformis)種の細菌の培養に特に適する。 The method according to the invention is particularly suitable for the cultivation of bacteria belonging to the genus Vitreostila, more particularly bacteria of the species Vitreoscilla filiformis.
上のように定義し、幾つかは既に記載した細菌は、一般的に水中に生息しており、特に海水中または温泉水中において認められ得る。使用され得る細菌の中で、例えば以下のものを挙げることができる:
ビトレオスチラ・フィリフォルミス(ATCC 15551)
ビトレオスチラ・ベッジアトイデス(Vitreoscilla beggiatoides) (ATCC 43181)
ベギアトア・アルバ(Beggiatoa alba) (ATCC 33555)
フレキシトリックス・ドロセアエ(Flexithrix dorotheae) (ATCC 23163)
ロイコトリックス・ムコール(Leucothrix mucor) (ATCC 25107)
スフェロチルス・ナタンス(Sphaerotilus natans) (ATCC 13338)。
Bacteria defined as above, some already described, generally live in water and can be found especially in seawater or hot spring water. Among the bacteria that can be used, mention may be made, for example, of:
Vitreostilla Filformis (ATCC 15551)
Vitreoscilla beggiatoides (ATCC 43181)
Beggiatoa alba (ATCC 33555)
Flexithrix dorotheae (ATCC 23163)
Leucothrix mucor (ATCC 25107)
Sphaerotilus natans (ATCC 13338).
好ましくは、本発明による方法は、番号15551でATCCに寄託された株に相当する細菌の培養に適用される。 Preferably, the method according to the invention is applied to the cultivation of bacteria corresponding to the strain deposited with the ATCC under number 15551.
用語「温泉水」は、その治療能力または入浴使用のために使用される温水または冷水を意味することが理解される。本発明は、温泉水または鉱泉水を使用できる。一般に、鉱泉水は摂取に適するが、温泉水の場合は必ずしもそうではない。これらの各水は、とりわけ、溶解したミネラルおよび/または微量元素を含む。これらの水は、その中に存在する特定の微量元素およびミネラルによって、特定の治療目的で使用されることが知られている。 The term “hot spring water” is understood to mean hot or cold water used for its therapeutic capacity or bathing use. In the present invention, hot spring water or mineral water can be used. In general, mineral water is suitable for ingestion, but not necessarily in the case of hot spring water. Each of these waters contains, inter alia, dissolved minerals and / or trace elements. These waters are known to be used for specific therapeutic purposes due to the specific trace elements and minerals present therein.
好ましくは、本発明による方法において、400mg/l以上の全ミネラル含量を示す温泉水および/または鉱泉水でできているものを使用する。 Preferably, in the process according to the invention, those made of hot spring water and / or mineral water showing a total mineral content of 400 mg / l or more are used.
本発明において、用語「全ミネラル含量」は、温泉水または鉱泉水中に存在するアニオンおよびカチオンの合計濃度を意味することが理解される。本発明による使用の温泉水または鉱泉水において、全ミネラル含量は、一般に400〜900mg/lである。 In the present invention, the term “total mineral content” is understood to mean the total concentration of anions and cations present in hot spring water or mineral water. In the hot spring water or mineral spring water used according to the invention, the total mineral content is generally between 400 and 900 mg / l.
本発明によって使用される温泉水および/または鉱泉水は、少なくとも700mg/lの全ミネラル含量、特に、少なくとも150mg/l、より好ましくは少なくとも360mg/lの炭酸塩および重炭酸塩の総濃度、ならびに特に2mg/lを超える炭酸ナトリウムおよび重炭酸ナトリウムの総濃度を有し得る。本発明による組成物に使用される水中の酸化ケイ素の濃度は、好ましくは少なくとも6mg/l、より好ましくは少なくとも9mg/lであり得る。 The hot spring water and / or mineral water used according to the present invention has a total mineral content of at least 700 mg / l, in particular a total concentration of carbonate and bicarbonate of at least 150 mg / l, more preferably at least 360 mg / l, and In particular, it may have a total concentration of sodium carbonate and sodium bicarbonate of more than 2 mg / l. The concentration of silicon oxide in the water used in the composition according to the invention may preferably be at least 6 mg / l, more preferably at least 9 mg / l.
本発明に使用される温泉水または鉱泉水は、例えば、Vittel産の水、Vichy盆地産の水、Uriage産の水、La Roche-Posay産の水、La Bourboule産の水、Enghien-les-Bains産の水、Saint Gervais-les-Bains産の水、Neris-les-Bains産の水、Allevard-les-Bains産の水、Digne産の水、Maizieres産の水、Neyrac-les-Bains産の水、Lons-le-Saunier産の水、Eaux-Bonnes産の水、Rochefort産の水、Saint Christau産の水、Les Fumades産の水、およびTercis-les-Bains産の水から選択可能である。 Hot spring water or mineral spring water used in the present invention is, for example, water from Vittel, water from Vichy Basin, water from Uriage, water from La Roche-Posay, water from La Bourboule, Enghien-les-Bains Water from Saint Gervais-les-Bains, water from Neris-les-Bains, water from Allevard-les-Bains, water from Digne, water from Maizires, water from Neyrac-les-Bains Water from Lons-le-Saunier, water from Eaux-Bonnes, water from Rochefort, water from Saint Christau, water from Les Fumades, and water from Tercis-les-Bains.
有利には、硫黄不含水、例えば、Vittel産の水、亜硫酸水を除いたVichy盆地産の水、La Roche-Posay産の水、La Bourboule産の水、Enghien-les-Bains産の水、Neris-les-Bains産の水、Digne産の水、Maizieres産の水、Neyrac-les-Bains産の水、Lons-le-Saunier産の水、Rochefort産の水、Saint Christau産の水、およびTercis-les-Bains産の水から選択される。 Sulfur-free water, for example, water from Vittel, water from the Vichy basin, excluding sulfite, water from La Roche-Posay, water from La Bourboule, water from Enghien-les-Bains, Neris -les-Bains water, Digne water, Maizieres water, Neyrac-les-Bains water, Lons-le-Saunier water, Rochefort water, Saint Christau water, and Tercis- Selected from water from les-Bains.
これらの水の中で、360mg/lを超える炭酸塩または重炭酸塩の総濃度を示す水は、Vittel産の水、La Bourboule産の水、Les Fumades産の水、Enghien-les-Bains産の水、La Roche-Posay産の水、Vichy盆地産の水およびUriage産の水である。 Among these waters, water with a total concentration of carbonate or bicarbonate exceeding 360 mg / l is water from Vittel, water from La Bourboule, water from Les Fumades, water from Enghien-les-Bains. Water from La Roche-Posay, Vichy basin and Uriage.
これらの水の中で、150mg/l〜360mg/lの炭酸塩または重炭酸塩の濃度を示す水は、Digne産の水、Maizieres産の水、Rochefort産の水またはSaint Gervais-les-Bains産の水である。 Among these waters, water with a carbonate or bicarbonate concentration of 150 mg / l to 360 mg / l is water from Digne, water from Maizires, water from Rochefort or from Saint Gervais-les-Bains. Of water.
これらの水の中で、少なくとも2mg/lの炭酸ナトリウムまたは重炭酸ナトリウムを含む水は、La Roche-Posay産の水、Vittel産の水、Vichy盆地産の水またはUriage産の水である。 Among these waters, water containing at least 2 mg / l sodium carbonate or bicarbonate is water from La Roche-Posay, water from Vittel, water from Vichy Basin or water from Uriage.
少なくとも9mg/lの酸化ケイ素を含む水は、La Roche-Posay産の水、Vittel産の水、Vichy盆地産の水またはUriage産の水である。 Water containing at least 9 mg / l silicon oxide is water from La Roche-Posay, water from Vittel, water from Vichy Basin or water from Uriage.
本発明の実施に特に適する温泉水または鉱泉水は、100mg/l以上、実際には140mg/lのカルシウムイオン濃度を有する。 Hot spring water or mineral spring water that is particularly suitable for the practice of the present invention has a calcium ion concentration of 100 mg / l or more, in fact 140 mg / l.
有利な実施形態によれば、温泉水または鉱泉水は、300mg/l以上の炭酸水素イオン濃度を有する。重炭酸塩としても知られている炭酸水素塩は、特に350mg/l以上の濃度で存在する。 According to an advantageous embodiment, the hot spring water or the mineral spring water has a bicarbonate ion concentration of 300 mg / l or more. The bicarbonate, also known as bicarbonate, is present in particular at a concentration of 350 mg / l or more.
有利な実施形態によれば、細菌は、少なくとも1種の温泉水を含む培地において培養される。後者は、特にVittel産の水、Vichy盆地産の水、Uriage産の水、La Roche-Posay産の水、La Bourboule産の水、またはEnghien-les-Bains産の水、特にVittel産の水、亜硫酸水を除いたVichy盆地産の水およびLa Roche-Posay産の水から選択可能である。 According to an advantageous embodiment, the bacteria are cultivated in a medium comprising at least one hot spring water. The latter are especially water from Vittel, water from the Vichy Basin, water from Uriage, water from La Roche-Posay, water from La Bourboule, or water from Enghien-les-Bains, especially water from Vittel, It is possible to select from water from Vichy basin excluding sulfite water and water from La Roche-Posay.
本発明による、特定の有利な結果を得られる水は、特に、La Roche-Posay産の水、およびVittel産の水、または同様の組成を有する水から選択される。 The water with which certain advantageous results are obtained according to the invention is selected in particular from water from La Roche-Posay and water from Vittel or water having a similar composition.
La Roche-Posay産の水は、同じ名前の泉から抽出され、重炭酸塩、カルシウム、ケイ酸塩およびセレニウムを含む水である。La Roche-Posay産の水は、およそ387mg/lの重炭酸イオン、およそ140mg/lのカルシウムイオンおよび少なくとも40mg/lの硫酸塩を一般に含む。 Water from La Roche-Posay is extracted from a spring of the same name and contains bicarbonate, calcium, silicate and selenium. Water from La Roche-Posay generally contains approximately 387 mg / l bicarbonate ion, approximately 140 mg / l calcium ion and at least 40 mg / l sulfate.
Vittel産の水は、カルシウムおよびミネラル塩(841mg/l)が豊富であり、特に202mg/lのカルシウム、402mg/lの重炭酸塩および336mg/lの硫酸塩を含む。 The water from Vittel is rich in calcium and mineral salts (841 mg / l), especially including 202 mg / l calcium, 402 mg / l bicarbonate and 336 mg / l sulfate.
培養は、以下の培地において特に実施できる: Culturing can be performed in particular in the following media:
組成物 濃度
自己消化酵母抽出物 0.5〜5g/l
ペプトン 0.5〜5g/l
無水グルコース 0.5〜7g/l
Heller微量元素 0.5〜5ml/l
CaCl2・10H2O 0.010〜0.200g/l
Composition Concentration Autolysis Yeast Extract 0.5-5g / l
Peptone 0.5-5g / l
Anhydrous glucose 0.5-7g / l
Heller trace element 0.5-5ml / l
CaCl 2・ 10H 2 O 0.010〜0.200g / l
組成物を蒸留水および/または鉱泉水もしくは温泉水で1000mlにする。 The composition is made up to 1000 ml with distilled water and / or mineral water or hot spring water.
使用され得るペプトンの中で、例えば、大豆パパインペプトンを挙げることができる。 Among the peptones that can be used, mention may be made, for example, of soy papain peptone.
この培地は、カタラーゼおよび硫化物を含まずに一般に使用される培地と区別される。Heller微量元素は、Hellerによって、Ann. Sci. Nat. Biol. Veg.、14、1〜223 (1953)に記載されている。それらは、細菌の培養のためではなくインビトロで培養される植物組織の栄養のためである、Hellerによって推奨される種々のミネラル元素の混合物である。 This medium is distinguished from the commonly used medium without catalase and sulfide. Heller trace elements are described by Heller in Ann. Sci. Nat. Biol. Veg., 14, 1-223 (1953). They are a mixture of various mineral elements recommended by Heller, not for the cultivation of bacteria, but for the nutrition of plant tissues cultured in vitro.
培養は、培養される細菌の種に適した適当な温度で実施できる。一般に、この温度は、株に依って18〜40℃である。培養培地のpHは、好ましくは5.5〜8である。 Culturing can be carried out at a suitable temperature suitable for the bacterial species to be cultured. In general, this temperature is 18-40 ° C. depending on the strain. The pH of the culture medium is preferably 5.5-8.
水1lあたりのHeller微量元素の組成は以下の通りである:
ZnSO4・7H2O 1g
MnSO4・H2O 0.076g
CuSO4・5H2O 0.003g
KI 0.010g
H3BO3 1g
AlCl3・6H2O 0.050g
NiCl2・6H2O 0.030g
The composition of Heller trace elements per liter of water is as follows:
ZnSO 4・ 7H 2 O 1g
MnSO 4・ H 2 O 0.076g
CuSO 4・ 5H 2 O 0.003g
KI 0.010g
H 3 BO 3 1g
AlCl 3・ 6H 2 O 0.050g
NiCl 2・ 6H 2 O 0.030g
前記温泉水または鉱泉水は、培養培地の水性相の全部または一部を置き換えることができる。これらは、したがって、水、特に、培養培地中に存在する蒸留水または浸透処理水との任意の割合での混合物として見出すことができる。 The hot spring water or mineral water can replace all or part of the aqueous phase of the culture medium. They can therefore be found as a mixture in any proportion with water, in particular distilled or osmotic water present in the culture medium.
培地の全ての元素を混合した後、温泉水および/または鉱泉水を含む培養培地を好都合に滅菌する。この段階は、当業者に既知の方法、例えば濾過または加熱による滅菌によって実施する。 After all the elements of the medium are mixed, the culture medium containing hot spring water and / or mineral water is conveniently sterilized. This step is carried out by methods known to those skilled in the art, such as filtration or sterilization by heating.
続いて培養培地に細菌を接種する。 Subsequently, the culture medium is inoculated with bacteria.
したがって本発明の別の主題は、先に定義したように、微生物を培養する方法または化粧品もしくは皮膚用有効成分を調製する方法であって、培養培地が(i)浸透処理水または蒸留水および(ii)温泉水の混合物を(i)/(ii)1〜100、特に1〜50、とりわけ1〜25の比で含むことを特徴とする方法である。 Accordingly, another subject of the invention is a method of culturing microorganisms or a method of preparing cosmetic or dermatological active ingredients as defined above, wherein the culture medium comprises (i) osmotic or distilled water and ( ii) A process characterized in that it comprises a mixture of hot spring water in a ratio of (i) / (ii) 1-100, in particular 1-50, in particular 1-25.
驚くべきことに、本発明に関連して、温泉水および/または鉱泉水を相対的に少ない割合で培養培地に包含させることにより、微生物に、包含される水がもっぱら蒸留水および/または浸透処理水である培地において培養された微生物の特性とは異なる有利な特性を付与できることが見出された。 Surprisingly, in the context of the present invention, by including a relatively small proportion of hot spring water and / or mineral spring water in the culture medium, the microorganism contains exclusively water that is contained in distilled water and / or osmotic treatment. It has been found that advantageous properties different from those of microorganisms cultured in a medium that is water can be imparted.
したがって、本発明の実施に適した培地では、温泉水または鉱泉水において、培地の調製のために導入される水の量は好ましくは少なくとも0.1%、特に0.1〜99.9%に相当する。良好な結果は、浸透処理水および/または蒸留水について、およそ1%または2%、例えば0.5〜20%、実際には0.5〜50%の温泉水濃度で得られるが、これらの濃度は、不都合無く増加させることができる。 Therefore, in a medium suitable for the practice of the present invention, the amount of water introduced for the preparation of the medium in hot spring water or mineral spring water preferably corresponds to at least 0.1%, in particular 0.1-99.9%. Good results are obtained for osmotic and / or distilled water at approximately 1% or 2%, for example 0.5-20%, indeed 0.5-50% hot spring water concentrations, but these concentrations are inconvenient It can be increased without.
既知の仕方では、方法は、特に細胞を培養培地から分離することによって細菌を培養の終わりに回収する少なくとも1段階を含む。 In a known manner, the method comprises at least one stage in which the bacteria are recovered at the end of the culture, in particular by separating the cells from the culture medium.
細菌を培養した後、バイオマスは、種々の既知の方法、例えば濾過によって、アルコール(エタノール、イソプロパノール、イソブタノール)を用いた凝固によって、スクレイプ予備層(デンプン、珪藻など)を有するシリンダでの乾燥によって、または凍結乾燥によって単離できる。例えば80℃における減圧下での予備濃縮は、この分離を改善する。 After culturing the bacteria, the biomass can be obtained by various known methods such as filtration, coagulation with alcohol (ethanol, isopropanol, isobutanol), and drying in a cylinder with a scrape pre-layer (starch, diatom, etc.). Or can be isolated by lyophilization. Preconcentration, for example at 80 ° C. under reduced pressure, improves this separation.
エンベロープを破裂させる操作は、例えば超音波の作用によって実施できる。加えて、抽出物は、アルコール、例えばエタノールまたはプロパノールを用いて調製できる。 The operation of rupturing the envelope can be performed, for example, by the action of ultrasonic waves. In addition, extracts can be prepared using alcohols such as ethanol or propanol.
リポ多糖類抽出物は、既知の方法にしたがって調製することもできる。例えば、NorisおよびRibbons、Methods in Microbiology、Vol. 5B、Academic Press (1971)を参照されたい。一般に使用される方法は、周知の「Westphal」方法(または関連する方法)であり、65℃でのフェノール/水混合物による抽出の実施にある。続いて抽出物を透析に付してフェノールを除去する。 The lipopolysaccharide extract can also be prepared according to a known method. See, for example, Noris and Ribbons, Methods in Microbiology, Vol. 5B, Academic Press (1971). A commonly used method is the well-known “Westphal” method (or related method), which is to perform extraction with a phenol / water mixture at 65 ° C. The extract is subsequently subjected to dialysis to remove phenol.
本発明は、先に定義したように、化粧品または皮膚用有効成分の調製方法であって、(i)ベギアトア目の系列に属する少なくとも1種の細菌を、主な炭素源としての単糖類および少なくとも1種の鉱泉水または温泉水を含む培地において培養し、次いで(ii)発酵後、細菌を培養培地から分離して前記細菌塊を回収する段階を含むことを特徴とする方法に特に関する。 The present invention provides a method for preparing an active ingredient for cosmetics or skin, as defined above, comprising: (i) at least one bacterium belonging to the order of Vegia toa, a monosaccharide as a main carbon source and at least It particularly relates to a method comprising culturing in a medium containing one mineral spring water or hot spring water, and then (ii) separating the bacteria from the culture medium after fermentation and recovering the bacterial mass.
発酵段階の終了の際に回収された細菌は、特に安定化および/または抽出処理に付すことができる。これは、化粧品または皮膚用組成物の調製においてまたはその調製のために一般に用いられ得る、このようにして得られる糸状菌の抽出物である。それ自体が既知の仕方において、抽出物は、したがって、特に濾過またはオートクレーブによって滅菌できる。 Bacteria recovered at the end of the fermentation stage can be subjected in particular to stabilization and / or extraction treatment. This is an extract of the filamentous fungus thus obtained that can be used generally in or for the preparation of cosmetic or dermatological compositions. In a manner known per se, the extract can therefore be sterilized, in particular by filtration or autoclaving.
用語「非光合成性の糸状菌の抽出物」は、前記細菌の培養からの上清、前記細菌の培養後に得られるバイオマス、またはバイオマスの処理によって得られる当該バイオマスの抽出物を同様に意味することが理解される。 The term “non-photosynthetic filamentous fungal extract” likewise means the supernatant from the culture of the bacteria, the biomass obtained after the cultivation of the bacteria, or the extract of the biomass obtained by processing of the biomass. Is understood.
本発明による抽出物を調製するために、前記細菌を本発明による方法によって培養することができ、次いで、得られるバイオマスから、例えば濾過、遠心分離、凝固および/または凍結乾燥によって分離できる。 In order to prepare the extract according to the invention, the bacteria can be cultured by the method according to the invention and then separated from the resulting biomass, for example by filtration, centrifugation, coagulation and / or lyophilization.
したがって、培養後、細菌を遠心分離によって濃縮する。得られたバイオマスをオートクレーブ処理する。このバイオマスを、凍結乾燥して、凍結乾燥された抽出物と称されるものを構成できる。当業者に既知の任意の凍結乾燥方法を用いて、この抽出物を調製できる。 Therefore, after culturing, the bacteria are concentrated by centrifugation. The obtained biomass is autoclaved. This biomass can be lyophilized to constitute what is referred to as a lyophilized extract. This extract can be prepared using any lyophilization method known to those skilled in the art.
このバイオマスからの上清画分を無菌容器内に濾過して、懸濁した粒子を除去することもできる。この上清画分を無菌状態下で無菌容器内に静かに注いでもよい。本発明の特定の実施形態によれば、こうして得られた上清画分を化粧品または皮膚用有効成分として使用する。 The supernatant fraction from the biomass can be filtered into a sterile container to remove suspended particles. This supernatant fraction may be gently poured into a sterile container under aseptic conditions. According to a particular embodiment of the invention, the supernatant fraction thus obtained is used as an active ingredient for cosmetics or skin.
驚くべきことに、本発明に関連して、少なくとも1種の温泉水または鉱泉水を含む、特に培養培地に存在する1〜100%の水を構成する培地における細菌の培養は、種々の発酵および単離段階の終了の際に得られる細菌に、温泉水および/または鉱泉水が補充されていないが浸透処理水または蒸留水のみを含む培地において培養された同じ細菌の特性とは異なる特定の特性を付与することが見出された。 Surprisingly, in the context of the present invention, the cultivation of bacteria in a medium comprising at least one hot spring water or mineral water, in particular comprising 1-100% of the water present in the culture medium, is subject to various fermentations and Specific characteristics that differ from those of the same bacteria cultured in a medium that is not supplemented with spring and / or mineral water but contains only osmotic or distilled water, at the end of the isolation phase Has been found to confer.
本発明の別の態様によれば、鉱泉水または温泉水によって細菌を培養するための培地の水の全部または一部の置換により、細菌の成長率を増加させ、したがって生産高を改善できる。 According to another aspect of the present invention, replacement of all or part of the medium water for culturing bacteria with mineral water or hot spring water can increase the growth rate of bacteria and thus improve yield.
生産高は、特に、制御された成長率および同一かつ制御された培養条件で少なくとも10%増加することができる。 Production can be increased by at least 10%, especially with controlled growth rates and identical and controlled culture conditions.
したがって本発明の別の主題は、先に定義されるように、好ましくは硫黄不含である少なくとも1種の温泉水または鉱泉水の、ビトレオスチラ属の細菌、特にビトレオスチラ・フィリフォルミスの活性および/または成長を改善するための薬剤としての使用である。 Accordingly, another subject of the invention is the activity of at least one spa or mineral water, preferably sulfur-free, of Vitreostila spp. Or use as a drug to improve growth.
本発明はまた、ベギアトア属またはビトレオスチラ属の細菌の成長および/または特性を改善する方法であって、温泉水および/または鉱泉水を培養培地に少なくとも1つの培養段階において添加することである方法にも関する。 The present invention also relates to a method for improving the growth and / or characteristics of a bacteria of the genus Begiatora or Vitreostila, wherein the spring water and / or mineral water is added to the culture medium in at least one culture stage. Also related.
上述のように、温泉水または鉱泉水は、好ましくは硫黄不含水であり、Vittel産の水、亜硫酸水を除くVichy盆地産の水およびLa Roche-Posay産の水から特に選択される。 As mentioned above, the hot spring water or mineral water is preferably sulfur-free water and is specifically selected from water from Vittel, water from the Vichy basin excluding sulfite water and water from La Roche-Posay.
本発明の別の主題は、先に定義されるように、非光合成性の糸状菌の培養に適した培養培地であり、前記培地中に存在する水は、少なくとも1%、特に1〜99.9%、好ましくは1〜25%の鉱泉水および/または温泉水を含む。 Another subject of the present invention is a culture medium suitable for the cultivation of non-photosynthetic filamentous fungi, as defined above, wherein the water present in said medium is at least 1%, in particular 1-99.9%. Preferably 1-25% mineral spring water and / or hot spring water.
本発明の別の主題は、本発明による方法によって得られる細菌、特にビトレオスチラ・フィリフォルミス、およびその抽出物、ならびに組成物におけるその使用でもあり、細菌、その抽出物、または組成物は、皮膚および/または身体表面成長物の状態を改善するのに使用される。 Another subject of the invention is also the bacteria obtained by the method according to the invention, in particular the Vitreostila filiformis, and extracts thereof, and their use in compositions, wherein the bacteria, extracts or compositions are skin And / or used to improve the condition of body surface growth.
本発明の別の主題は、したがって、組成物、特に化粧品または皮膚用組成物であって、生理学的に許容される培地において、上記方法によって得られるビトレオスチラ属の少なくとも1種の細菌、または後者の抽出物を含むことを特徴とする組成物である。 Another subject of the invention is therefore a composition, in particular a cosmetic or dermatological composition, in a physiologically acceptable medium, at least one bacterium of the genus Vitreostilla obtained by the above method, or the latter It is a composition characterized by including an extract.
本発明によって使用される組成物は、化粧品および皮膚科学分野において考えられる用途、特に経口または局所用途に適した全ての形態で提供できる。 The compositions used according to the invention can be provided in all forms suitable for applications considered in the cosmetic and dermatological field, in particular oral or topical applications.
用語「局所」は、局所適用による皮膚または身体表面成長物への使用を意味することが好ましくは理解される。用語「皮膚」は、別途示さない限り、頭皮または粘膜も包含する。 The term “topical” is preferably understood to mean use on the skin or body surface growth by topical application. The term “skin” also includes the scalp or mucosa unless otherwise indicated.
したがって本発明による組成物は、体の任意の皮膚領域、毛髪、爪または粘膜に適用することができ、当業者によって任意の適切な製剤形態で与えられ得る。当該組成物は、特に、水性または油性の溶液または懸濁液、水中油または油中水または多重エマルジョン、シリコーンエマルジョン、マイクロエマルジョンまたはナノエマルジョン、水性または油性ゲル、または液体、ペースト状もしくは固形の無水生成物の形態で提供され得る。 The composition according to the invention can therefore be applied to any skin area, hair, nails or mucous membranes of the body and can be given in any suitable formulation form by a person skilled in the art. Such compositions are in particular aqueous or oily solutions or suspensions, oil-in-water or water-in-oil or multiple emulsions, silicone emulsions, microemulsions or nanoemulsions, aqueous or oily gels, or liquid, pasty or solid anhydrous It can be provided in the form of a product.
皮膚への局所適用のために、組成物は、特に、ローションもしくは血清型の水性もしくは油性の溶液もしくは分散物、水性相における脂肪相の分散(O/W)もしくはその逆(W/O)によって得られる、ミルク型の液体もしくは半液体コンシステンシーとのエマルジョン、または、水性もしくは無水クリームもしくはゲル型のソフトコンシステンシー、他にはマイクロカプセルもしくは微粒子との懸濁液もしくはエマルジョン、あるいはイオンおよび/もしくは非イオン型の小胞分散物の形態を有し得る。組成物はまた、パッチまたは放出制御製剤の形態で存在することもできる。これらの組成物は通常の方法にしたがって調製される。 For topical application to the skin, the composition may in particular be prepared by an aqueous or oily solution or dispersion of lotion or serotype, dispersion of the fatty phase in the aqueous phase (O / W) or vice versa (W / O). The resulting emulsion with a milk-type liquid or semi-liquid consistency, or an aqueous or anhydrous cream or gel-type soft consistency, else a suspension or emulsion with microcapsules or microparticles, or ions and / or It can have the form of a non-ionic vesicle dispersion. The composition can also be present in the form of a patch or controlled release formulation. These compositions are prepared according to the usual methods.
これらは、水性、アルコール性、または水性/アルコール性溶液の形態、あるいはクリーム、ゲル、エマルジョンまたはフォームの形態、あるいはまた加圧噴射剤も含むエアロゾル組成物の形態で毛髪に使用されてもよい。 They may be used on the hair in the form of an aqueous, alcoholic, or aqueous / alcoholic solution, or in the form of a cream, gel, emulsion or foam, or in the form of an aerosol composition that also includes a pressurized propellant.
組成物は、眼用に、滴の形態で提供することができ、また、経口摂取用に、カプセル、顆粒、ゲル、チューイングペースト、シロップまたは錠剤の形態で提供できる。 The composition can be provided in the form of drops for the eye and in the form of capsules, granules, gels, chewing pastes, syrups or tablets for ingestion.
本発明による組成物の種々の構成物質の量は、検討されている、当該分野で従来的に使用される量である。 The amounts of the various constituents of the composition according to the invention are those conventionally used in the field under consideration.
これらの組成物は、特に、顔、手、足、主に解剖学上のひだ、または体を洗う、保護する、処理する、またはケアするためのクリーム(例えば、デイクリーム、ナイトクリーム、メークアップ除去用クリーム、ファンデーションクリーム、またはサンクリーム)、皮膚または毛髪に静置されるマスク、リキッドファンデーション、メークアップ除去用ミルク、保護用またはケア用ボディミルク、サンミルク、ローション、皮膚をケアするためのゲルまたはフォーム、例えばクレンジングローション、サンローション、人工日焼けローション、入浴用組成物、殺菌剤を含む脱臭組成物、アフターシェーブゲルまたはローション、脱毛クリーム、虫刺され(insect stings or bites)に対応するための組成物、鎮痛組成物、またはある一定の皮膚病、例えば湿疹、酒さ、乾癬、苔癬もしくは重症の掻痒を治療するための組成物を構成する。 These compositions are especially creams for washing, protecting, treating or caring for the face, hands, feet, mainly anatomical folds, or body (e.g. day cream, night cream, makeup) (Removal cream, foundation cream, or sun cream), masks placed on the skin or hair, liquid foundation, make-up removal milk, body milk for protection or care, sun milk, lotion, for skin care Gels or foams such as cleansing lotions, sun lotions, artificial tanning lotions, bathing compositions, deodorizing compositions containing bactericides, aftershave gels or lotions, hair removal creams, compositions to accommodate insect stings or bites Product, analgesic composition, or certain skin diseases such as dampness Constitutes rosacea, psoriasis, a composition for treating pruritus of lichen or severe.
本発明による組成物はまた、クレンジングソープまたはバーを構成する固形調製物からなることもできる。 The composition according to the invention can also consist of a solid preparation constituting a cleansing soap or bar.
組成物はまた、加圧噴射剤も含むエアロゾル組成物の形態に詰めることもできる。 The composition can also be packed in the form of an aerosol composition that also includes a pressurized propellant.
本発明による組成物は、ヘアケア組成物、特にシャンプー、ヘアセットローション、トリートメントローション、スタイリングクリームまたはゲル、染料組成物(特に酸化染料組成物)、任意選択的にはシャンプー染液の形態、ヘアリストラクチャリングローション、パーマネントウエーブ組成物(特にパーマネントウエーブの第1工程用組成物)、抜け毛に対抗するためのローションまたはゲル、抗寄生虫用シャンプーなどであってもよい。 The composition according to the invention comprises a hair care composition, in particular a shampoo, a hair set lotion, a treatment lotion, a styling cream or gel, a dye composition (especially an oxidative dye composition), optionally in the form of a shampoo dye, It may be a structuring lotion, a permanent wave composition (particularly a composition for the first step of a permanent wave), a lotion or gel for combating hair loss, an antiparasitic shampoo, and the like.
組成物は、経口使用のためのもの、例えば歯磨き粉であってもよい。この場合、組成物は、経口使用のための組成物に従来的なアジュバントおよび添加剤、特に界面活性剤、増粘剤、保湿剤、研磨剤、例えばシリカ、種々の有効成分、例えばフッ化物、特にフッ化ナトリウム、および任意選択的に甘味剤、例えばサッカリンナトリウムを含んでよい。 The composition may be for oral use, for example toothpaste. In this case, the composition comprises adjuvants and additives that are conventional to compositions for oral use, in particular surfactants, thickeners, humectants, abrasives such as silica, various active ingredients such as fluoride, In particular, sodium fluoride and optionally a sweetening agent such as sodium saccharin may be included.
組成物がエマルジョンであるとき、脂肪相の割合は、組成物の全重量に対して5重量%〜80重量%、好ましくは5重量%〜50重量%の範囲であり得る。エマルジョン形態で組成物において使用されるオイル、ワックス、乳化剤および共乳化剤は、化粧品分野で従来的に使用されるものから選択される。乳化剤および共乳化剤は、組成物の全重量に対して0.3重量%〜30重量%、好ましくは0.5重量%〜20重量%の範囲の割合で組成物中に存在する。加えて、エマルジョンは、脂質小胞を含んでよい。 When the composition is an emulsion, the proportion of the fatty phase can range from 5% to 80% by weight, preferably from 5% to 50% by weight relative to the total weight of the composition. The oils, waxes, emulsifiers and coemulsifiers used in the composition in emulsion form are selected from those conventionally used in the cosmetic field. The emulsifier and coemulsifier are present in the composition in a proportion ranging from 0.3% to 30% by weight, preferably from 0.5% to 20% by weight, relative to the total weight of the composition. In addition, the emulsion may contain lipid vesicles.
組成物が油性溶液またはゲルであるとき、脂肪相は組成物の全重量の90%超を示し得る。 When the composition is an oily solution or gel, the fatty phase can represent more than 90% of the total weight of the composition.
既知の仕方では、化粧品組成物は、化粧品分野で従来的なアジュバント、例えば親水性または親油性のゲル化剤、親水性または親油性の添加剤、防腐剤、抗酸化剤、溶剤、香料、充填剤、スクリーニング剤、匂い吸収剤および着色剤を含んでもよい。これらの種々のアジュバントの量は、化粧品分野で従来的に使用される量、例えば、組成物の全重量の0.01%〜10%である。これらのアジュバントは、性質に依って、脂肪相、水性相および/または脂質小球内に導入されてよい。 In a known manner, the cosmetic composition comprises conventional adjuvants in the cosmetic field, such as hydrophilic or lipophilic gelling agents, hydrophilic or lipophilic additives, preservatives, antioxidants, solvents, perfumes, fillings. Agents, screening agents, odor absorbers and colorants may be included. The amounts of these various adjuvants are those conventionally used in the cosmetic field, for example from 0.01% to 10% of the total weight of the composition. Depending on the nature, these adjuvants may be introduced into the fatty phase, the aqueous phase and / or the lipid globules.
本発明で使用され得るオイルまたはワックスとして、鉱油(流動ワセリン)、植物油(シアバターの液体画分、ヒマワリ油)、動物油(ペルヒドロスクアレン)、合成油(ピュアセリンオイル)、シリコーン油またはワックス(シクロメチコン)およびフッ化油(パーフルオロポリエーテル)、蜜蝋、カルナウバ蝋またはパラフィン蝋を挙げることができる。これらのオイルに脂肪アルコールおよび脂肪酸(ステアリン酸)を添加できる。 Oils or waxes that can be used in the present invention include mineral oil (fluid petrolatum), vegetable oil (liquid fraction of shea butter, sunflower oil), animal oil (perhydrosqualene), synthetic oil (pure serine oil), silicone oil or wax ( Mention may be made of cyclomethicone) and fluorinated oils (perfluoropolyether), beeswax, carnauba wax or paraffin wax. Fatty alcohols and fatty acids (stearic acid) can be added to these oils.
本発明で使用され得る乳化剤として、例えば、ステアリン酸グリセリル、ポリソルベート60およびTefose(登録商標)63の名称でGattefosseによって販売されているPEG-6/PEG-32/ステアリン酸グリコール混合物を挙げることができる。 As emulsifiers that can be used in the present invention, mention may be made, for example, of PEG-6 / PEG-32 / glycol stearate mixtures sold by Gattefosse under the name glyceryl stearate, polysorbate 60 and Tefose® 63. .
本発明で使用され得る溶剤として、低級アルコール、特にエタノールおよびイソプロパノール、またはプロピレングリコールを挙げることができる。 As solvents that can be used in the present invention, mention may be made of lower alcohols, in particular ethanol and isopropanol, or propylene glycol.
本発明で使用され得る親水性ゲル化剤として、カルボキシビニルポリマー(カルボマー)、アクリル共重合体、例えばアクリレート/アルキルアクリレート共重合体、ポリアクリルアミド、多糖類、例えばヒドロキシプロピルセルロース、天然ガムおよびクレイを挙げることができ、また、本発明で使用され得る親油性ゲル化剤として、修飾クレイ、例えばBentones(登録商標)、脂肪酸の金属塩、例えばステアリン酸アルミニウムおよび疎水性シリカ、エチルセルロースまたはポリエチレンを挙げることができる。 Hydrophilic gelling agents that can be used in the present invention include carboxyvinyl polymers (carbomers), acrylic copolymers such as acrylate / alkyl acrylate copolymers, polyacrylamides, polysaccharides such as hydroxypropylcellulose, natural gums and clays. Examples of lipophilic gelling agents that can be used in the present invention include modified clays such as Bentones®, metal salts of fatty acids such as aluminum stearate and hydrophobic silica, ethylcellulose or polyethylene. Can do.
有利な実施形態において、本発明による組成物は、水中油(O/W)組成物、特に親油性有効成分を含む組成物である。そのような組成物は、出願EP641557に記載されるような、ラメラ液晶コーティングが施された油球に特に基づいている。化粧品または皮膚用組成物は、水性相に分散された、ラメラ液晶コーティングが施された油球から形成される水中油型のエマルジョンから構成され、それぞれの油球は、化粧学的または皮膚科学的に活性である少なくとも1種の親油性化合物を含み、少なくとも1種の親油性界面活性剤、少なくとも1種の親水性界面活性剤および少なくとも1種の脂肪酸から得られるモノラメラまたはオリゴラメラ層でそれぞれコーティングされており、コーティングされた油球は、500ナノメートル未満の平均直径を有し、水性相は塩基性剤を溶解状態で含む。 In an advantageous embodiment, the composition according to the invention is an oil-in-water (O / W) composition, in particular a composition comprising a lipophilic active ingredient. Such a composition is based in particular on an oil sphere with a lamellar liquid crystal coating, as described in application EP 641557. Cosmetic or dermatological compositions are composed of oil-in-water emulsions formed from oil spheres with a lamellar liquid crystal coating dispersed in an aqueous phase, each oil sphere being cosmetic or dermatological And at least one lipophilic surfactant, at least one lipophilic surfactant, at least one hydrophilic surfactant and at least one fatty acid and each coated with a monolamellar or oligolamellar layer. The coated oil spheres have an average diameter of less than 500 nanometers and the aqueous phase contains a basic agent in the dissolved state.
本発明による組成物がケラチン物質の美容的処理に使用されるとき、油性相に存在する有効成分は、例えば、メラニン調節剤、リポ調節剤、抗脂漏性剤、老化防止剤、UV放射に対抗する薬剤、角質溶解剤、抗菌剤、抗真菌剤、フケ防止剤、抜け毛に対抗する薬剤、毛髪染剤、ヘアブリーチまたはコンディショナーから選択される。 When the composition according to the invention is used for the cosmetic treatment of keratin substances, the active ingredients present in the oily phase are, for example, melanin regulators, lipomodulators, antiseborrheic agents, anti-aging agents, UV radiation. It is selected from drugs to counteract, keratolytic agents, antibacterial agents, antifungal agents, anti-dandruff agents, agents against hair loss, hair dyes, hair bleaches or conditioners.
本発明に関連して使用され得る、皮膚および/または毛髪の処理のための有効成分の例として、以下の化合物を挙げることができる:D-α-トコフェロール、DL-α-トコフェロール、D-α-酢酸トコフェリル、DL-α-酢酸トコフェリル、パルミチン酸アスコルビル、ビタミンFグリセリド、ビタミンD類、特にビタミンD2、ビタミンD3、レチノール、レチニルエステル、パルミチン酸レチニル、プロピオン酸レチニル、β-カロチン、D-パンテノール、ファルネソール、酢酸ファルネシル、必須脂肪酸に富むホホバ油およびクロフサスグリ油、5-(n-オクタノイル)サリチル酸、サリチル酸、クエン酸、乳酸およびグリコール酸などのα-ヒドロキシ酸のアルキルエステル、アジア酸、マデカッソ酸、アジアチコシド、ツボクサ(Centella asiatica)の全抽出物、β-グリシルレチン酸、α-ビサボロール、セラミド、例えば2-オレオイルアミノ-1,3-オクタデカン、フィタントリオール、乳スフィンゴミエリン、多不飽和必須脂肪酸に富む海洋起源のリン脂質、エトキシキン、ローズマリーの抽出物、バルサム抽出物、ケルセチン、乾燥微小藻類の抽出物(AlgatecからのAlgoxan Red)、オクチルメトキシシンナメート(ParsolMCX、Givaudan-Roure)、ブチルメトキシジベンゾイルメタン(Parsol 1789、Givaudan-Roure)、オクチルトリアゾン(Uvinul T150、BASF)、黄色、茶色、黒色もしくは赤色酸化鉄、または酸化チタン、これらは、マイクロメートルまたはナノメートルの形態、あるいはコーティングされた形態であってよい。 Examples of active ingredients for skin and / or hair treatment that can be used in connection with the present invention may include the following compounds: D-α-tocopherol, DL-α-tocopherol, D-α -Tocopheryl acetate, DL-α-tocopheryl acetate, ascorbyl palmitate, vitamin F glycerides, vitamin Ds, especially vitamin D 2 , vitamin D 3 , retinol, retinyl ester, retinyl palmitate, retinyl propionate, β-carotene, D-panthenol, farnesol, farnesyl acetate, jojoba oil and blackcurrant oil rich in essential fatty acids, alkyl esters of α-hydroxy acids such as 5- (n-octanoyl) salicylic acid, salicylic acid, citric acid, lactic acid and glycolic acid, asiatic acid , Madecassoic acid, Asiaticoside, Centella asiatica total extract, β-glycyl Extracts of phospholipids, ethoxyquin, rosemary of marine origin rich in retinoic acid, α-bisabolol, ceramide such as 2-oleoylamino-1,3-octadecane, phytantriol, milk sphingomyelin, polyunsaturated essential fatty acids , Balsam extract, quercetin, dried microalgae extract (Algoxan Red from Algatec), octyl methoxycinnamate (ParsolMCX, Givaudan-Roure), butyl methoxydibenzoylmethane (Parsol 1789, Givaudan-Roure), octyl triazone (Uvinul T150, BASF), yellow, brown, black or red iron oxide, or titanium oxide, which may be in micrometer or nanometer form, or coated form.
本発明による組成物中に存在する、温泉水において培養されたバイオマスまたはその抽出物の量は、使用される抽出物のタイプに依って、所望の活性を得るために当業者によって調整されるであろう。表示すると、組成物中の量は、組成物の全重量に対して0.001%〜10重量%の間、好ましくは0.01%〜5重量%であり、特に、少なくとも0.1重量%であり得る。 The amount of biomass or extract thereof cultivated in hot spring water present in the composition according to the invention can be adjusted by the person skilled in the art to obtain the desired activity, depending on the type of extract used. I will. When expressed, the amount in the composition is between 0.001% and 10% by weight, preferably 0.01% to 5% by weight, in particular at least 0.1% by weight, relative to the total weight of the composition.
本発明はまた、皮膚および/または身体表面成長物の状態を改善するための方法であって、先に定義するように温泉水または鉱泉水を含む培地において培養することによって得られる少なくとも1種の細菌、その抽出物の1種、またはそれらを含む組成物を皮膚および/または身体表面成長物に適用する方法も含む。 The present invention is also a method for improving the condition of skin and / or body surface growth, which is obtained by culturing in a medium containing hot spring water or mineral spring water as defined above. Also included is a method of applying a bacterium, one of its extracts, or a composition comprising them to skin and / or body surface growth.
本発明の一態様によれば、本発明は、組成物、特に化粧品または皮膚用組成物の調製方法であって、先に定義するように温泉水または鉱泉水を含む培地において培養することによって得られる少なくとも1種の細菌、またはその抽出物の1種を、投与方法に適切な、少なくとも1種の生理学的に許容される培地およびアジュバントと混合する方法に関する。 According to one aspect of the present invention, the present invention provides a method for the preparation of a composition, in particular a cosmetic or dermatological composition, which is obtained by culturing in a medium containing hot spring water or mineral spring water as defined above. Relates to a method of mixing at least one bacterium, or one of its extracts, with at least one physiologically acceptable medium and adjuvant suitable for the method of administration.
本発明を以下の実施例により詳細に説明する。 The invention is illustrated in detail by the following examples.
バイオマスの調製
培養培地の調製:
組成:
*酵母抽出物 2g
*大豆パパインペプトン 2g
*グルコース 2g
*Heller微量元素 2ml
*CaCl2・2H2O 66.21mg
*La Roche-Posay産の温泉水 1リットルについて適量
Preparation of biomass Preparation of culture medium:
composition:
* Yeast extract 2g
* Soybean papain peptone 2g
* Glucose 2g
* Heller trace element 2ml
* CaCl 2・ 2H 2 O 66.21mg
* Appropriate amount for 1 liter of hot spring water from La Roche-Posay
培地のpHを1モルのH3PO4溶液によって5.00に調整する。培地を滅菌オートクレーブによって121℃で30分間滅菌する。周囲温度まで冷却後、pHを1モルのKOH溶液の添加により7.20に再調整する。 The pH of the medium is adjusted to 5.00 with 1 molar H 3 PO 4 solution. The medium is sterilized at 121 ° C. for 30 minutes in a sterile autoclave. After cooling to ambient temperature, the pH is readjusted to 7.20 by addition of 1 molar KOH solution.
培養:
番号15551でATCCに寄託されたビトレオスチラ・フィリフォルミスを1%で培地に接種した後、培養物を26℃、かつ100回転/分での軌道振とう下に置く。48時間の成長後、培養物を8000gで15分間遠心分離する。ペレットを回収し、次いで、121℃で30分間オートクレーブ処理する。このバイオマスは、評価試験に使用できる。
culture:
After inoculating the medium with Vitreostilla filiformis deposited with the ATCC under number 15551 at 1%, the culture is placed under orbital shaking at 26 ° C. and 100 rpm. After 48 hours of growth, the culture is centrifuged at 8000 g for 15 minutes. The pellets are collected and then autoclaved at 121 ° C. for 30 minutes. This biomass can be used for evaluation tests.
温泉水を用いてまたは用いないで得られるバイオマスの効果の比較
この研究の目的は、浸透処理水によって再構成された培養培地において培養することによって得られたバイオマス(表では「バイオマス」と記録される)、La Roche-Posay産の温泉水によって再構成された培地において培養することによって得られたバイオマス(「バイオマスLRP」)、およびLa Roche-Posay産の温泉水(「温泉水LRP」)の、ヒトケラチノサイト培養物における差次的遺伝子発現への影響を判定しようとすることである。
Comparison of the effects of biomass obtained with or without hot spring water The purpose of this study was to obtain biomass obtained by culturing in a culture medium reconstituted with osmotic water (recorded as `` biomass '' in the table) ), Biomass obtained by culturing in a medium reconstituted with hot spring water from La Roche-Posay (`` biomass LRP ''), and hot spring water from La Roche-Posay (`` hot spring water LRP '') In an attempt to determine the effect on differential gene expression in human keratinocyte cultures.
バイオマスは、微生物(番号15551でATCCに寄託されたビトレオスチラ・フィリフォルミス)をLa Roche-Posay産の温泉水の存在下または非存在下で培養することによって得、2%の濃度で導入する。 Biomass is obtained by culturing microorganisms (Vitreostilla filiformis deposited at ATCC under number 15551) in the presence or absence of hot spring water from La Roche-Posay and is introduced at a concentration of 2%.
これらの結果は、ケラチノサイト培養物上でのコルネオデスモシンおよびLEP16マーカーのRT-qPCRによる分析によって確認する。 These results are confirmed by RT-qPCR analysis of corneodesmosine and LEP16 markers on keratinocyte cultures.
ケラチノサイト培養物において、La Roche-Posay産の温泉水において培養されたバイオマスのみがコルネオデスモシンおよびLEP16の発現を刺激する。浸透処理水またはLa Roche-Posay産の温泉水で培養されたバイオマスは、ケラチノサイトについて、これらのマーカー遺伝子の発現に影響を及ぼさない。同時に、対照として使用されたMerck製の超純水も、検討される遺伝子の発現に影響を及ぼさない。 In keratinocyte cultures, only biomass cultured in hot spring water from La Roche-Posay stimulates the expression of corneodesmosine and LEP16. Biomass cultured in osmotic water or hot spring water from La Roche-Posay does not affect the expression of these marker genes for keratinocytes. At the same time, Merck's ultrapure water used as a control has no effect on the expression of the genes studied.
La Roche-Posay産の水でのビトレオスチラ・フィリフォルミスの培養と浸透処理水でのビトレオスチラ・フィリフォルミスの培養との間の発現の差
ビトレオスチラ・フィリフォルミスバイオマスにおいて発現されるタンパク質を分離および視覚化するための手段として二次元電気泳動法を使用し、一方ではLa Roche-Posay産の水において培養し、他方では浸透処理水において培養した。
Difference in expression between Vitreostilla filiformis culture in water from La Roche-Posay and Vitroostila filiformis in osmotic treated water Isolate and express proteins expressed in Vitreostilla filiformis biomass Two-dimensional electrophoresis was used as a means for visualization, cultivated in water from La Roche-Posay on the one hand and in osmotic water on the other hand.
この分析方法は、「水平の」一次元目(これは等電点電気泳動またはIEFである)においてタンパク質をそのpHiの関数として分離することである。この分離は、IPGストリップとしても知られている、固定化されたpH勾配を含むゲルを介して起こる。続いてタンパク質を、「垂直」移動の二次元目において、その分子量の関数として分離する。結果は、2Dゲルのタンパク質が非常に豊富であることを示し、後者は、6kDa〜100kDaの間の分子量範囲に分布され、多数のタンパク質が酸性pH値の領域にある。画像の迅速な分析により、6個の異なるスポットが示され、一方では、La Roche-Posay産の水において培養されたバイオマスにおける2つのタンパク質の過剰発現であり、他方では、浸透処理水において培養されたバイオマスにおいてより発現されているように見られる4つのタンパク質である。 The method of analysis is to separate proteins as a function of their pHi in the “horizontal” first dimension (which is isoelectric focusing or IEF). This separation occurs through a gel containing an immobilized pH gradient, also known as an IPG strip. The protein is then separated as a function of its molecular weight in the second dimension of the “vertical” movement. The results show that 2D gel proteins are very abundant, the latter being distributed in the molecular weight range between 6 kDa and 100 kDa, with many proteins in the region of acidic pH values. Rapid analysis of the image shows 6 different spots, one being overexpression of two proteins in biomass grown in water from La Roche-Posay and the other in culture in osmotic water. There are four proteins that appear to be more expressed in biomass.
これらの結果は、La Roche-Posay産の水において培養されたバイオマスにおけるタンパク質の発現と比較して、浸透処理水において培養されたバイオマスにおけるタンパク質の発現のレベルに差が存在することを示す。 These results indicate that there is a difference in the level of protein expression in biomass cultured in osmotic treated water compared to protein expression in biomass cultured in La Roche-Posay water.
Vittel産の水を用いた成長の増加
10リットルの発酵槽における連続様式でのビトレオスチラ・フィリフォルミスの培養試験を、浸透処理水(対照試験)およびVittel産の鉱泉水(2%で)で部分的に再構成された培地から出発して実施した。連続培養方法による成長度を0.12h-1で固定し、培養条件は2つの試験で同一であった。バイオマスは、連続的に採取した培養物体積を遠心分離することによって濃縮した。600nmでの吸光度の測定により、培養物の成長を監視できる。得られたスラッジをオートクレーブによって121℃で30分間安定化させた。採取されたスラッジの固形分および量により、遠心分離された培養物体積から、対応する培養物の細胞濃度を(g/lで)求めることができる。
Increased growth with water from Vittel
The culture test of Vitreostilla filformis in a continuous manner in a 10 liter fermenter starts with a medium partially reconstituted with osmotic water (control test) and mineral water from Vittel (2%). Carried out. The growth rate by the continuous culture method was fixed at 0.12 h −1 , and the culture conditions were the same in the two tests. Biomass was concentrated by centrifuging continuously harvested culture volumes. The growth of the culture can be monitored by measuring the absorbance at 600 nm. The obtained sludge was stabilized at 121 ° C. for 30 minutes by an autoclave. From the collected sludge solids and amount, the cell concentration of the corresponding culture can be determined (in g / l) from the centrifuged culture volume.
試験の要約表: Exam summary table:
結果:
浸透処理水によって再構成された培地における対照培養物と比較して、Vittel産の水の使用は、細菌の成長を改善し、細胞収率は13%増加する。
result:
Compared to control cultures in media reconstituted with osmotic water, the use of water from Vittel improves bacterial growth and increases cell yield by 13%.
ビトレオスチラ・フィリフォルミス抽出物を含む組成物 Composition comprising Vitreostilla filiformis extract
相A、B、CおよびDを調製し、続いて混合する: Prepare phases A, B, C and D, followed by mixing:
このようにして得られた組成物は、朝および/または晩に、顔、首、手および/または体全体に適用できる。 The composition thus obtained can be applied to the face, neck, hands and / or whole body in the morning and / or evening.
Claims (6)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0754957A FR2915898B1 (en) | 2007-05-10 | 2007-05-10 | PROCESS FOR THE PREPARATION OF ACTIVE INGREDIENTS ON THERMAL WATER AND COMPOSITIONS CONTAINING SAME |
FR0754957 | 2007-05-10 | ||
US94596907P | 2007-06-25 | 2007-06-25 | |
US60/945,969 | 2007-06-25 | ||
PCT/EP2008/055644 WO2008138839A2 (en) | 2007-05-10 | 2008-05-07 | Preparation of cosmetic active principles by culturing vitreoscilla on thermal water and compositions comprising them |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2010526792A JP2010526792A (en) | 2010-08-05 |
JP5670181B2 true JP5670181B2 (en) | 2015-02-18 |
Family
ID=38515806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010506932A Active JP5670181B2 (en) | 2007-05-10 | 2008-05-07 | Methods for preparing active ingredients in hot spring water and compositions containing them |
Country Status (6)
Country | Link |
---|---|
US (2) | US20110064835A1 (en) |
EP (1) | EP2144995B1 (en) |
JP (1) | JP5670181B2 (en) |
ES (1) | ES2543351T3 (en) |
FR (1) | FR2915898B1 (en) |
WO (1) | WO2008138839A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2988607B1 (en) * | 2012-03-27 | 2016-07-15 | Oreal | USE OF A CULTURE LYSATE OF A BACTERIUM OF THE GENUS VITREOSCILLA SP. FOR PREVENTING AND / OR TREATING HYPERSEBORRHEIC CONDITIONS OF SCALP. |
FR3038839B1 (en) * | 2015-07-13 | 2020-04-24 | Clinique Des Celestins | VICHY WATER TO MODULATE BACTERIAL GROWTH |
US10806769B2 (en) | 2016-03-31 | 2020-10-20 | Gojo Industries, Inc. | Antimicrobial peptide stimulating cleansing composition |
JP2019510036A (en) | 2016-03-31 | 2019-04-11 | ゴジョ・インダストリーズ・インコーポレイテッド | A detergent composition comprising probiotic / prebiotic active ingredients |
AU2017365019A1 (en) | 2016-11-23 | 2019-07-11 | Gojo Industries, Inc. | Sanitizer composition with probiotic/prebiotic active ingredient |
WO2021059408A1 (en) * | 2019-09-25 | 2021-04-01 | 肇 福永 | Biocompatible nanoparticles |
FR3117001B1 (en) | 2020-12-07 | 2024-05-03 | Oreal | Device and method for cleaning the skin and/or keratin fibers |
FR3117036B1 (en) | 2020-12-07 | 2023-04-21 | Oreal | Compositions for cleaning keratin materials |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3022A (en) * | 1843-03-30 | Machine for bending stibrups for paddle-wheels of steam and other | ||
FR2283223A1 (en) * | 1974-08-26 | 1976-03-26 | Synthelabo | Thio-bacteria of beggiatoaceae species - industrially grown in vitro and used in cosmetic and pharmaceutical compsns |
CH634877A5 (en) * | 1978-11-01 | 1983-02-28 | Nestle Sa | PROCESS FOR THE PREPARATION OF A SUBSTANCE HAVING BACTERIOSTATIC ACTIVITY. |
JPS6248396A (en) * | 1985-08-24 | 1987-03-03 | Shimane Univ | Production of glutathione |
AT387035B (en) | 1986-04-24 | 1988-11-25 | Caola Kozmetikai | METHOD FOR GROWING ALGAE WITH IMPROVED BIOLOGICAL PROPERTIES |
EP0349607A1 (en) | 1987-11-24 | 1990-01-10 | BOGDANYNE FORGACS, Olga | Preparation and use of plants of improved biological value |
FR2693654B1 (en) * | 1992-07-20 | 1994-08-26 | Oreal | Medicinal product, in particular immunomodulatory, containing envelopes or fractions of envelopes of non-photosynthetic and non-fruiting filamentous bacteria, and its preparation. |
FR2719768B1 (en) * | 1994-05-10 | 1996-06-14 | Oreal | Use of extracts of filamentous bacteria as cosmetic agents against skin aging. |
FR2721208B1 (en) * | 1994-06-16 | 1996-08-02 | Oreal | Composition for topical use containing an antioxidant and a bacterial extract, and use of this composition. |
FR2722691A1 (en) * | 1994-07-22 | 1996-01-26 | Oreal | COSMETIC AND / OR DERMATOLOGICAL COMPOSITION CONTENT COMBATING ACNE OR AGING WITH THERMAL OR MINERAL WATER AND AN ACTIVE INGREDIENT FOR |
JP3949720B2 (en) * | 1995-09-07 | 2007-07-25 | ロレアル | Use of extracts from non-photosynthetic filamentous bacteria and compositions containing them |
FR2762782B1 (en) * | 1997-05-05 | 1999-06-11 | Oreal | COMPOSITION COMPRISING A MICROORGANISM CULTURE MEDIUM AND USE THEREOF |
FR2788434B1 (en) * | 1999-01-15 | 2001-05-11 | Oreal | USE OF AT LEAST ONE EXTRACT OF AT LEAST ONE NON-PHOTOSYNTHETIC FILAMENTOUS BACTERIA AS A SLIMMING AGENT |
ATE255879T1 (en) * | 2000-06-29 | 2003-12-15 | Johnson & Johnson Consumer | METHOD FOR PROMOTING THE ABSORPTION OF NUTRIENTS, WATER AND/OR OXYGEN INTO THE SKIN |
FR2838056B1 (en) * | 2002-04-08 | 2007-05-18 | Oreal | USE OF EXTRACT OF NON-PHOTOSYNTHETIC NON-FRUCTIFIANT FILAMENTARY BACTERIUM AS AN AGENT INCREASING ENDOGENOUS SUPEROXIDE DISMUTASE SYNTHESIS |
US20030224077A1 (en) * | 2002-04-08 | 2003-12-04 | Societe L'oreal S.A. | Administration of extracts of nonfruiting nonphotosynthetic filamentous bacteria for increasing the endogenous synthesis of superoxide dismutase |
FR2846236B1 (en) * | 2002-10-24 | 2006-07-28 | Oreal | USE OF AN OXYSTEROL OR DERIVATIVE FOR THE TREATMENT OF DRY SKIN OR DRY SCALP |
US20040137023A1 (en) * | 2002-10-24 | 2004-07-15 | L'oreal | 5-Cholesten-3beta, 25-diol-7-one, esters and ethers thereof, particularly for the treatment of dry skin and scalp |
FR2855044A1 (en) * | 2003-05-19 | 2004-11-26 | Oreal | USE OF EXTRACT OF NON-PHOTOSYNTHETIC NON-FRUCTIFIANT FILAMENTARY BACTERIUM FOR REINFORCING MATERIALS |
FR2862062B1 (en) * | 2003-11-06 | 2005-12-23 | Oreal | LIPID A AND TOPICAL COMPOSITION, IN PARTICULAR COSMETIC, COMPRISING IT |
US7727973B2 (en) * | 2003-11-06 | 2010-06-01 | L'oreal | Lipid A-type compound and composition containing it |
EP1863505A2 (en) * | 2005-03-11 | 2007-12-12 | L'Oréal | Use of a non-photosynthetic, non-fructifying filamentous bacteria extract as a gamma-delta t lymphocyte activation and/or protection agent |
FR2918886B1 (en) * | 2007-07-17 | 2010-01-08 | Oreal | USE OF AT LEAST ONE CULTIVE BACTERIAL EXTRACT ON THERMAL WATER FOR THE TREATMENT OF SENSITIVE SKIN, MUCOUS AND SKIN LEATHER |
FR2918885B1 (en) * | 2007-07-17 | 2009-08-28 | Oreal | USE OF CULTIVATED BACTERIUM EXTRACT IN THERMAL WATER TO DECREASE POCKETS AND / OR PERIOCULAR CERNES |
FR2918884B1 (en) * | 2007-07-17 | 2010-01-15 | Oreal | USE OF CULTIVE BACTERIAL EXTRACTS ON THERMAL WATER AS ANTI-REDNESS AGENT |
-
2007
- 2007-05-10 FR FR0754957A patent/FR2915898B1/en not_active Expired - Fee Related
-
2008
- 2008-05-07 EP EP20080750160 patent/EP2144995B1/en active Active
- 2008-05-07 JP JP2010506932A patent/JP5670181B2/en active Active
- 2008-05-07 US US12/599,308 patent/US20110064835A1/en not_active Abandoned
- 2008-05-07 WO PCT/EP2008/055644 patent/WO2008138839A2/en active Application Filing
- 2008-05-07 ES ES08750160.7T patent/ES2543351T3/en active Active
-
2016
- 2016-11-16 US US15/353,173 patent/US11371010B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20110064835A1 (en) | 2011-03-17 |
ES2543351T3 (en) | 2015-08-18 |
WO2008138839A2 (en) | 2008-11-20 |
EP2144995A2 (en) | 2010-01-20 |
US20170226470A1 (en) | 2017-08-10 |
FR2915898B1 (en) | 2009-06-12 |
JP2010526792A (en) | 2010-08-05 |
FR2915898A1 (en) | 2008-11-14 |
WO2008138839A3 (en) | 2009-01-22 |
US11371010B2 (en) | 2022-06-28 |
EP2144995B1 (en) | 2015-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11371010B2 (en) | Process for the preparation of active principles on thermal water and compositions comprising them | |
US9770474B2 (en) | Bacterial extracts cultured in thermal waters comprising anti-redness agents | |
US9393266B2 (en) | Bacterial extracts cultured in thermal waters for reducing bags and/or dark circles around the eyes | |
CN103415531B (en) | For treating the peptide of skin disorder | |
US20090022819A1 (en) | Bacterial extracts cultured in thermal waters for the treatment of dry skin | |
EP1638991A2 (en) | Cosmetic or dermopharmaceutical composition for reducing the signs of cutaneous ageing | |
JP2005501805A (en) | Process for the production of proteins by fermentation of microorganisms of Thermus family, mixtures of proteins thus obtained, and cosmetic compositions containing them | |
EP2976060B1 (en) | Exopolysaccharide for the treatment and/or care of the skin, mucous membranes and/or nails | |
JP7022700B2 (en) | A composition for use in the treatment and / or prevention of juvenile acne vulgaris, which comprises a Harungana madagascariensis leaf extract, and a method for preparing the same. | |
JP2000511942A (en) | Use of petroselinic acid for the treatment of inflammation | |
JP2007517842A (en) | Use of Acmelola lacea extract for botox-like action in anti-wrinkle cosmetic composition | |
US5653984A (en) | Extract of periwinkle seed and compositions containing the same | |
DE69900547T2 (en) | COSMETIC COMPOSITION CONTAINING A MIXTURE FOR STIMULATING INTERLEUKIN-6 PRODUCTION | |
RU2170584C2 (en) | Ribosomal fraction and composition containing thereof | |
EP3338763B1 (en) | Use of rhamnolipids for the cosmetic treatment of reactive skin | |
JP2003137744A (en) | Hair-restoring and growing agent | |
KR20220089816A (en) | Cosmetic composition for improving atopic dermatitis containing anti-inflammatory herbal fermented peptide and method for manufacturing the same | |
JPH1142082A (en) | White bacterium of genus sphingomonas | |
WO2023149795A1 (en) | Method for producing an entomological compound with a keratolytic effect | |
KR20140013339A (en) | Method for producing microorganism lamella construct and composition comprising microorganism lamella construct | |
CN116761588A (en) | Combination of Vischig hot spring water and an extract of at least one bacterium from the species Vitreoscilla filiformis cultivated on a medium comprising at least one Vischig hot spring water | |
JPH10330273A (en) | Production of preparation for external use for skin | |
MXPA97010255A (en) | Ribosomal fraction and composition that the conti |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110421 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20130624 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20130702 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131002 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20131009 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20131202 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20131209 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20131216 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20140428 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140828 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20141014 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20141117 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20141217 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5670181 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |